Misoprostol in the treatment of duodenal ulcer refractory to H2-blocker therapy: A placebo-controlled, multicenter, double-blind, randomized trial
- 27 July 1987
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 83 (1), 27-31
- https://doi.org/10.1016/0002-9343(87)90575-4
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Prostaglandin E1 (Misoprostol) overcomes the adverse effect of chronic cigarette smoking on duodenal ulcer healingDigestive Diseases and Sciences, 1986
- Efficacy of misoprostol (twice daily dosage) in acute healing of duodenal ulcerDigestive Diseases and Sciences, 1986
- A multicenter international controlled comparison of two dosage regimes of misoprostol and cimetidine in the treatment of duodenal ulcer in out-patientsDigestive Diseases and Sciences, 1985
- Misoprostol in the treatment of duodenal ulcerDigestive Diseases and Sciences, 1985
- Misoprostol, a synthetic PGE1 analog, in the treatment of duodenal ulcersDigestive Diseases and Sciences, 1985
- Treatment of 'cimetidine-resistant' chronic duodenal ulcers with ranitidine or cimetidine: a randomised multicentre study.Gut, 1984
- Refractory duodenal ulcer.Gut, 1984
- Comparison of two doses of cimetidine and placebo in the treatment of duodenal ulcer: a multicentre trial.Gut, 1979
- Placebos, Antacids and Cimetidine for Duodenal UlcerNew England Journal of Medicine, 1978
- Cimetidine versus intensive antacid therapy for duodenal ulcerGastroenterology, 1978